Related Experiment Video
Updated: Jun 17, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
PharmVar GeneFocus: CYP4F2
Pablo Zubiaur1, Cristina Rodríguez-Antona2,3, Erin C Boone4
1Clinical Pharmacology Department, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM) and Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IP), Madrid, Spain.
The Pharmacogene Variation Consortium (PharmVar) now includes novel star alleles for the CYP4F2 gene. This genetic variation affects drug and vitamin metabolism, impacting warfarin dosing and other medications.
Area of Science:
- Pharmacogenomics
- Human Genetics
- Drug Metabolism
Background:
- The CYP4F2 gene is polymorphic and plays a role in metabolizing various substances.
- Genetic variations in CYP4F2 influence vitamin K metabolism, affecting warfarin dosage.
- CYP4F2 also impacts the metabolism of drugs like imatinib and fingolimod, and endogenous compounds such as vitamin E.
Purpose of the Study:
- To provide a comprehensive overview of CYP4F2 genetic variation.
- To report the characterization of 14 new star alleles (CYP4F2*4 through *17).
- To describe the integration of PharmVar data into PharmGKB and CPIC.
Main Methods:
- Utilized the Pharmacogene Variation Consortium (PharmVar) as a global repository.
- Cataloged and characterized novel star (*) allele nomenclature for CYP4F2.
- Described the application of PharmVar haplotype data by PharmGKB and CPIC.
Main Results:
- Comprehensive summary of CYP4F2 genetic variations.
- Characterization of 14 novel star alleles: CYP4F2*4 to CYP4F2*17.
- Detailed how PharmVar data is used by PharmGKB and CPIC.
Conclusions:
- PharmVar provides essential nomenclature for CYP4F2 genetic variations.
- Understanding CYP4F2 alleles is crucial for personalized medicine, particularly warfarin pharmacogenetics.
- The cataloged variations and their integration into knowledgebases support clinical implementation.
More Related Videos
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Hepatic Drug Clearance: Role of Transporters
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...